34.27

1.39% 0.47

After Hours: 34.27

Simulations Plus Inc (SLP)

Overview News Price History Option Chain Financials Why SLP Down? Discussions Forecast Stock Split Dividend History

Simulations Plus Inc stock is traded at $34.27, with a volume of 124.99K. It is up +1.39% in the last 24 hours and up +22.66% over the past month. Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.

Previous Close:

$33.80

Open:

$34.26

24h Volume:

124.99K

Relative Volume:

0.52

Market Cap:

$688.57M

Revenue:

$66.98M

Net Income/Loss:

$9.65M

P/E Ratio:

71.40

EPS:

0.48

Net Cash Flow:

$10.19M

1W Performance:

+2.30%

1M Performance:

+22.66%

6M Performance:

-14.65%

1Y Performance:

-12.91%

1-Day Range:

$33.88

$34.50

1-Week Range:

$33.17

$34.50

52-Week Range:

$24.00

$51.22

Simulations Plus Inc Stock (SLP) Company Profile

Name

Simulations Plus Inc

Sector

Healthcare (1174)

Industry

Health Information Services (62)

Phone

661-723-7723

Address

800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA

Employee

247

Twitter

@SimulationsPlus

Next Earnings Date

2025-01-07

Latest SEC Filings

SLP's Discussions on Twitter

Compare SLP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLP Simulations Plus Inc	34.27	688.57M	66.98M	9.65M	10.19M	0.48
VEEV Veeva Systems Inc	237.07	38.49B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	75.30	13.01B	8.26B	66.00M	1.17B	0.3682
DOCS Doximity Inc	58.97	11.01B	516.85M	174.11M	217.38M	0.87
HQY Healthequity Inc	110.57	9.58B	1.15B	96.70M	-161.99M	1.09
TEM Tempus Ai Inc	57.19	9.00B	640.44M	-743.28M	-206.93M	-11.29

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-15-24	Initiated	Stephens	Overweight
Jul-29-24	Initiated	KeyBanc Capital Markets	Overweight
Jul-16-24	Initiated	JMP Securities	Mkt Perform
Jun-28-24	Initiated	William Blair	Outperform
May-09-23	Initiated	BTIG Research	Buy
Oct-26-21	Upgrade	Craig Hallum	Hold → Buy
Jan-12-21	Downgrade	Craig Hallum	Buy → Hold
Oct-16-20	Initiated	Raymond James	Outperform
Sep-08-20	Initiated	Oppenheimer	Outperform
Jan-06-20	Initiated	Craig Hallum	Buy

View All

Simulations Plus Inc Stock (SLP) Latest News

Jan 29, 2025

William Blair Analysts Reduce Earnings Estimates for SLP - MarketBeat

Jan 29, 2025

Jan 26, 2025

KeyCorp Forecasts Strong Price Appreciation for Simulations Plus (NASDAQ:SLP) Stock - Defense World

Jan 26, 2025

Jan 25, 2025

Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 - MarketBeat

Jan 25, 2025

Simulations Plus, Inc. (NASDAQ:SLP) Shares Acquired by Tributary Capital Management LLC - MarketBeat

Jan 25, 2025

Jan 24, 2025

JPMorgan Chase & Co. Boosts Stake in Simulations Plus, Inc. (NASDAQ:SLP) - Defense World

Jan 24, 2025

JPMorgan Chase & Co. Boosts Holdings in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat

Jan 24, 2025

Jan 22, 2025

Simulations Plus, Inc. and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus®? Enhancements - Marketscreener.com

Jan 22, 2025

Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements - Business Wire

Jan 22, 2025

Jan 20, 2025

Simulations Plus (SLP) to Report Q2 Earnings: What's in Store? - MSN

Jan 20, 2025

Jan 16, 2025

World Bank warns that US tariffs could reduce global growth outlook -January 16, 2025 at 01:03 pm EST - Marketscreener.com

Jan 16, 2025

Jan 15, 2025

There May Be Reason For Hope In Simulations Plus' (NASDAQ:SLP) Disappointing Earnings - Yahoo Finance

Jan 15, 2025